Literature DB >> 23328210

Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution.

Arseima Y Del Valle-Pinero1, Hendrick E Van Deventer, Nicolaas H Fourie, Angela C Martino, Nayan S Patel, Alan T Remaley, Wendy A Henderson.   

Abstract

BACKGROUND: Abnormal gastrointestinal permeability has been linked to irritable bowel syndrome (IBS). The lactulose-to-mannitol ratio is traditionally used to assess small intestine permeability while sucralose and sucrose are used to assess colonic and gastric permeability respectively. We used a single 4-probe test solution to assess permeability throughout the gastrointestinal tract in IBS patients and healthy controls by measuring the recovery of the probes in urine after ingestion using a modified liquid chromatography mass spectrometry protocol.
METHODS: Fasting participants (N=59) drank a permeability test solution (100ml: sucralose, sucrose, mannitol, and lactulose). Urine was collected over a 5-h period and kept frozen until analysis. Urinary sugar concentrations were measured using a liquid chromatography/triple quadruple mass spectrometer.
RESULTS: Colonic permeability was significantly lower in IBS patients when compared to healthy controls (p=0.011). Gastric and small intestinal permeability did not significantly differ between the groups.
CONCLUSIONS: The study demonstrates the clinical potential of this non-invasive method for assessing alterations in gastrointestinal permeability in patients with IBS. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23328210      PMCID: PMC3594104          DOI: 10.1016/j.cca.2012.12.032

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  28 in total

1.  Rapid and simultaneous determination of lactulose and mannitol in urine, by HPLC with pulsed amperometric detection, for use in studies of intestinal permeability.

Authors:  S C Fleming; M S Kapembwa; M F Laker; G E Levin; G E Griffin
Journal:  Clin Chem       Date:  1990-05       Impact factor: 8.327

Review 2.  Intestinal permeability: an overview.

Authors:  I Bjarnason; A MacPherson; D Hollander
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

3.  Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid.

Authors:  A Berstad; G Arslan; G Folvik
Journal:  Scand J Gastroenterol       Date:  2000-01       Impact factor: 2.423

4.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

5.  Measurement of urinary sugars by HPLC in the estimation of intestinal permeability: evaluation in pediatric clinical practice.

Authors:  D Willems; S Cadranel; W Jacobs
Journal:  Clin Chem       Date:  1993-05       Impact factor: 8.327

6.  A sensitive enzymatic assay for the determination of sucrose in serum and urine.

Authors:  Masanori Seimiya; Susumu Osawa; Nobuo Hisae; Tadayuki Shishido; Taketo Yamaguchi; Fumio Nomura
Journal:  Clin Chim Acta       Date:  2004-05       Impact factor: 3.786

7.  Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease.

Authors:  Jeremy A Tibble; Gudmundur Sigthorsson; Russell Foster; Ian Forgacs; Ingvar Bjarnason
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

8.  Comparative assessment of small intestinal and colonic permeability in HIV-infected homosexual men.

Authors:  F C Obinna; G Cook; T Beale; S Dave; D Cunningham; S C Fleming; E Claydon; J W Harris; M S Kapembwa
Journal:  AIDS       Date:  1995-09       Impact factor: 4.177

Review 9.  Advances in clinical laboratory tests for inflammatory bowel disease.

Authors:  Robert M Nakamura; Mariko Matsutani; Mary Barry
Journal:  Clin Chim Acta       Date:  2003-09       Impact factor: 3.786

Review 10.  The epidemiology of irritable bowel syndrome in North America: a systematic review.

Authors:  Yuri A Saito; Philip Schoenfeld; G Richard Locke
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

View more
  19 in total

1.  Increased Gut Permeability in First-degree Relatives of Children with Irritable Bowel Syndrome or Functional Abdominal Pain.

Authors:  Mark McOmber; Danny Rafati; Kevin Cain; Sridevi Devaraj; Erica M Weidler; Margaret Heitkemper; Robert J Shulman
Journal:  Clin Gastroenterol Hepatol       Date:  2019-05-14       Impact factor: 11.382

2.  Simultaneous gas-chromatographic urinary measurement of sugar probes to assess intestinal permeability: use of time course analysis to optimize its use to assess regional gut permeability.

Authors:  Maliha Shaikh; Kumar Rajan; Christopher B Forsyth; Robin M Voigt; Ali Keshavarzian
Journal:  Clin Chim Acta       Date:  2015-01-12       Impact factor: 3.786

3.  Alleviation of Metabolic Endotoxemia by Milk Fat Globule Membrane: Rationale, Design, and Methods of a Double-Blind, Randomized, Controlled, Crossover Dietary Intervention in Adults with Metabolic Syndrome.

Authors:  William R Quarles; Avi Pokala; Emily L Shaw; Joana Ortega-Anaya; Lisa Hillmann; Rafael Jimenez-Flores; Richard S Bruno
Journal:  Curr Dev Nutr       Date:  2020-07-25

Review 4.  Sucralose and Cardiometabolic Health: Current Understanding from Receptors to Clinical Investigations.

Authors:  Sydney Risdon; Sylvain Battault; Alonso Romo-Romo; Matthieu Roustit; Loic Briand; Grégory Meyer; Paloma Almeda-Valdes; Guillaume Walther
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

5.  Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation.

Authors:  Keith C Summa; Robin M Voigt; Christopher B Forsyth; Maliha Shaikh; Kate Cavanaugh; Yueming Tang; Martha Hotz Vitaterna; Shiwen Song; Fred W Turek; Ali Keshavarzian
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

6.  Lysozyme association with circulating RNA, extracellular vesicles, and chronic stress.

Authors:  Sarah K Abey; Yuana Yuana; Paule V Joseph; Natnael D Kenea; Nicolaas H Fourie; LeeAnne B Sherwin; Gregory E Gonye; Paul A Smyser; Erin S Stempinski; Christina M Boulineaux; Kristen R Weaver; Christopher K E Bleck; Wendy A Henderson
Journal:  BBA Clin       Date:  2016-12-20

7.  Dietary Red Meat Adversely Affects Disease Severity in a Pig Model of DSS-Induced Colitis Despite Reduction in Colonic Pro-Inflammatory Gene Expression.

Authors:  Tina S Nielsen; Marlene Fredborg; Peter K Theil; Yuan Yue; Lærke V Bruhn; Vibeke Andersen; Stig Purup
Journal:  Nutrients       Date:  2020-06-09       Impact factor: 5.717

8.  NMR spectroscopy enables simultaneous quantification of carbohydrates for diagnosis of intestinal and gastric permeability.

Authors:  Sarah Stryeck; Angela Horvath; Bettina Leber; Vanessa Stadlbauer; Tobias Madl
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

9.  An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients.

Authors:  Carmela Cosola; Maria Teresa Rocchetti; Ighli di Bari; Paola Maria Acquaviva; Valentina Maranzano; Simone Corciulo; Agostino Di Ciaula; Domenica Maria Di Palo; Flavia Maria La Forgia; Sergio Fontana; Maria De Angelis; Piero Portincasa; Loreto Gesualdo
Journal:  Toxins (Basel)       Date:  2021-05-05       Impact factor: 4.546

10.  The Gastrointestinal Pain Pointer: A Valid and Innovative Method to Assess Gastrointestinal Symptoms.

Authors:  Wendy A Henderson; Bridgett Rahim-Williams; Kevin H Kim; LeeAnne B Sherwin; Sarah K Abey; Angela C Martino; Nicolaas H Fourie; Margaret M Heitkemper; Anthony P Zuccolotto
Journal:  Gastroenterol Nurs       Date:  2017 Sep/Oct       Impact factor: 0.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.